10X GENOMICS, INC. - Annual Financials - Balance Sheet (SEC)
Updated on January 3, 2026.
Related Topics: SEC Topic List.
Data Source: SEC.
See details in table below.
You can see similar for other companies.
10X GENOMICS, INC. - Annual Balance Sheet
(In Thousands of USD, Except Per Share Amounts)
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| Cash and cash equivalents | 344067 | 359284 | |
| Marketable securities | 49335 | 29411 | |
| Accounts receivable, net | 87862 | 114832 | |
| Inventory | 83107 | 73706 | |
| Prepaid expenses and other current assets | 20016 | 18789 | |
| Total current assets | 584387 | 596022 | |
| Property and equipment, net | 252648 | 279571 | |
| Operating lease right-of-use assets | 57290 | 65361 | |
| Goodwill | 4511 | 4511 | |
| Intangible assets, net | 15671 | 16616 | |
| Other noncurrent assets | 4129 | 3062 | |
| Total assets | 918636 | 965143 | |
| Accounts payable | 12909 | 15738 | |
| Accrued compensation and related benefits | 33615 | 30105 | |
| Accrued expenses and other current liabilities | 41165 | 56648 | |
| Deferred revenue | 20658 | 13150 | |
| Operating lease liabilities | 9286 | 11521 | |
| Total current liabilities | 117633 | 127162 | |
| Operating lease liabilities, noncurrent | 73327 | 83849 | |
| Deferred revenue, noncurrent | 12513 | 8814 | |
| Other noncurrent liabilities | 5029 | 4275 | |
| Total liabilities | 208502 | 224100 | |
| Commitments and contingencies (Note 7) | 0 | 0 | |
| Preferred stock, $0.00001 par value; 100,000,000 shares authorized, no shares issued or outstanding as of December 31, 2024 and 2023 | 0 | 0 | |
| Common stock, $0.00001 par value; 1,100,000,000 shares authorized (Class A 1,000,000,000, Class B 100,000,000); 122,291,837 (Class A 108,235,004, Class B 14,056,833) and 119,095,362 (Class A 105,038,529, Class B 14,056,833) shares issued and outstanding as of December 31, 2024 and 2023, respectively | 2 | 2 | |
| Additional paid-in capital | 2177672 | 2025890 | |
| Accumulated deficit | -1467047 | -1284420 | |
| Accumulated other comprehensive loss | -493 | -429 | |
| Total stockholders equity | 2 | 2025890 | 805743 |
| Total liabilities and stockholders equity | 918636 | 965143 | |
| Preferred Stock, Par Value (in dollars per share) | 0 | 0 | |
| Preferred Stock, Shares Authorized (in shares) | 100000 | 100000 | |
| Preferred Stock, Shares Issued (in shares) | 0 | 0 | |
| Preferred Stock, Shares Outstanding (in shares) | 0 | 0 | |
| Common Stock, Par Value (in dollars per share) | 0 | 0 | |
| Common Stock, Shares Authorized (in shares) | 1100000 | 1000000 | |
| Common Stock, Shares Issued (in shares) | 108235.004 | 14056.833 | |
| Common Stock, Shares Outstanding (in shares) | 122291.837 | 14056.833 |